Page last updated: 2024-11-05

trimethoprim and Soft Tissue Neoplasms

trimethoprim has been researched along with Soft Tissue Neoplasms in 1 studies

Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.

Soft Tissue Neoplasms: Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Riganti, M1
Charoenlarp, P1
Punpoowong, B1
Bunnag, D1
Harinasuta, T1

Other Studies

1 other study available for trimethoprim and Soft Tissue Neoplasms

ArticleYear
Subcutaneous phycomycosis mimics elephantiasis.
    The Southeast Asian journal of tropical medicine and public health, 1987, Volume: 18, Issue:4

    Topics: Adult; Anti-Infective Agents; Dermatomycoses; Diagnosis, Differential; Drug Combinations; Elephantia

1987